Itamar Medical

Itamar Medical is a multinational company focused on the development, manufacturing and sales of medical devices related to respiratory sleep disorders. The company is headquartered in Caesarea, Israel[1] and is owned by ZOLL Medical Corporation. The company is a medical device company[2][3] providing continuum of care in the area of sleep disorder[4] based on its WatchPAT diagnostic devices and early diagnosis of Atherosclerosis.[5][6][7]

Itamar Medical
IndustryMedical Technology
Founded1995 (1995)
HeadquartersCaesarea
Key people
Giora Yaron, Gilad Glick (President)
Revenue33.2M
Number of employees
184 (2019)
ParentZOLL Medical Corporation
Websitewww.itamar-medical.com

Company overview

Itamar Medical was founded in 1995 as a developer of devices for assessing vascular defects. Its early products included technology for early detection of heart disease (EndoPAT) and detection of sleep disorders[8] (WatchPAT).[9][10][11] The company is named after Itamar Yaron (one of the founders' brothers), who was killed in Yom Kippur War when trying to rescue an injured soldier and was later awarded with a Medal of Courage.[12] Itamar's headquarter is located in Caesarea, Israel and has offices in the US, Japan and the Netherlands.

In 2007, the company went public on the Tel Aviv Stock Exchange and the on the Nasdaq. In 2011, the company made its first step on the Indian market.[13] In 2012, the company's WatchPAT started being distributed in Russia by Medical Diagnostic Methods.[14]

In 2020, the company raised $40 million on the NASDAQ[15][16] and won the SleepTech award for 2020.[17]

In 2021, the company was acquired by ZOLL Medical Corporation and its stock delisted.[18]

Company's devices

References
  1. וינרב, גלי (2 August 2020). "Itamar Medical climbs the corona and leaves the sleep laboratories behind". globes. Gali Winrav.
  2. "tamar Medical Ltd. American Depository Shares (ITMR)". nasdaq.
  3. "Itamar Medical Ltd. – American – Consensus Indicates Potential 34.3% Upside". directorstalkinterviews. Charlotte Edwards. 21 March 2021.
  4. "Market Live 2021- Global Home Sleep Screening Devices Market Can Deliver up to High CAGR over the next Few Years | Koninklijke Philips N.V., Garmin, ResMed, WebMD, Cleveland Medical Devices, NovaSom, Itamar Medical". mccourier. Data Bridge Market Research.
  5. "Itamar Medical Ltd info". bloomberg.
  6. "Covid-19 has made sleep clinics risky, which is where Itamar Medical's disposable home sleep apnea diagnosis kit comes in". globes. Gali Weinreb. 8 May 2020.
  7. "Itamar Medical reports record revenues in the third quarter of 2020". talniri.
  8. "Most Recent Annual Report". annualreports.
  9. "איתמר מדיקל הודיעה על הארכת חוזה עם קייזר - המניה מזנקת ב-14%". walla. ליאור זנו. 4 March 2010.
  10. "ויולה הופכת לבעלת המניות הגדולה באיתמר מדיקל ותשקיע בה עד 28.4 מיליון דולר". TheMarker. ערן אזרן.
  11. "אין הכרח בבדיקה במעבדה כדי לאבחן הפרעות שינה". הארץ.
  12. "גיורא ירון מ'איתמר' מספר על אחיו - "פצע עמוק נפער במשפחתנו"". Bizportal.
  13. גביזון, יורם (31 December 2010). "Itamar Medical's first step in the Indian market". הארץ. Yoram Gavizon.
  14. "איתמר מדיקל חודרת לרוסיה". news1. פיטרס דניאל.
  15. "Itamar CEO: Market potential $ 1 billion". israelbursa. Einav Cohen.
  16. "Itamar Medical raises $35m on Nasdaq". Globes. February 2, 2020.
  17. "Itamar Medical won the SleepTech Award from the US National Sleep Foundation for 2020". e-med. 6 October 2020.
  18. "ZOLL Announces Closing of Acquisition of Itamar Medical" (Press release). Business Wire. December 16, 2021.
  19. "Itamar Medical Announces Results from Multi-Center Study Validate Use of WatchPAT™ in Diagnosing Sleep Apnea in Patients with AFib". globenewswire (Press release). 8 December 2020.
  20. "Itamar Medical wins National Sleep Foundation award". israel21c. 3 November 2020.
  21. "איתמר מדיקל קיבלה אישור FDA לשיווק גרסה משופרת של ה-WatchPAT". TheMarker.
  22. גביזון, יורם (4 January 2011). "Itamar Medical enters the US $ 3 billion market". הארץ. Yoram Gavizon.
  23. Publishing, BIBA (March 27, 2009). "Study shows finger device may help predict heart events".
  24. דאר, צורי (21 April 2004). "Itamar Medical has received FDA approval for a device for assessing vascular defects; Has completed a $ 5 million fundraiser". הארץ. Zori Dar.
  25. "Itamar signs Medtronic deal for sleep device — Globes". en.globes.co.il. March 17, 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.